I appreciate your input, but curious as to why you are here then. Genuine question - are you just monitoring SNT's thread to warn off investors?
I have taken into account some slagging off of Garry Phillips that I have read. To be honest I don't know whether it's justified disgruntlement or not.
That said, I think the case seemed pretty compelling for changing PSX (Pharmaxis) to Syntara, and I like what SNT now have to offer over the next 12 months (4 x trials underway, cash runway of 12 months, positive Ph1 results for SNT-5505, Fiona Wood scar treatment recognition, etc), but appreciate that everyone has a different view. Cheers.
I appreciate your input, but curious as to why you are here...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.3¢ |
Change
-0.001(2.27%) |
Mkt cap ! $59.04M | |||
| Open | High | Low | Value | Volume |
| 4.4¢ | 4.4¢ | 4.2¢ | $39.11K | 895.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 752779 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.4¢ | 200000 | 1 |
View Market Depth
| Last trade - 15.58pm 04/10/2024 (20 minute delay) ? |
| SNT (ASX) Chart |